US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
ES2133588T3
(es)
*
|
1993-11-22 |
1999-09-16 |
Upjohn Co |
Esteres de hidroxiacetil-piperazin-fenil-oxazolidinonas sustituidas.
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
NZ295528A
(en)
*
|
1994-11-15 |
1999-03-29 |
Upjohn Co |
Bicyclic oxazine and thiazine oxazolidinone antibacterials
|
ES2163004T3
(es)
*
|
1995-02-03 |
2002-01-16 |
Upjohn Co |
Feniloxazolidinona sustituida por un anillo heteroaromatico como agente antimicrobiano.
|
AU702752B2
(en)
*
|
1995-05-11 |
1999-03-04 |
Pharmacia & Upjohn Company |
Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
|
KR100463772B1
(ko)
*
|
1995-09-01 |
2005-11-09 |
파마시아 앤드 업존 캄파니 엘엘씨 |
4내지8원헤테로사이클릭환에탄소-탄소결합을갖는페닐옥사졸리디논
|
US5883093A
(en)
*
|
1995-09-12 |
1999-03-16 |
Pharmacia & Upjohn Company |
Phenyloxazolidinone antimicrobials
|
ES2214546T3
(es)
*
|
1995-09-15 |
2004-09-16 |
PHARMACIA & UPJOHN COMPANY |
N-oxidos de aminoariloxazolidinona.
|
ZA968661B
(en)
*
|
1995-11-17 |
1998-04-14 |
Upjohn Co |
Oxazolidinone antibacterial agent with tricyclic substituents.
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
*
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
US6107519A
(en)
*
|
1997-11-07 |
2000-08-22 |
Pharmacia & Upjohn Company |
Process to produce oxazolidinones
|
CN1167701C
(zh)
*
|
1996-04-11 |
2004-09-22 |
法玛西雅厄普约翰美国公司 |
制备噁唑烷酮胺的方法
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
KR100307211B1
(ko)
*
|
1997-05-24 |
2001-11-30 |
손 경 식 |
옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
|
US6037354A
(en)
*
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
JP2002513424A
(ja)
*
|
1997-07-11 |
2002-05-08 |
ファルマシア・アンド・アップジョン・カンパニー |
チアジアゾリルおよびオキサジアゾリルフェニルオキサゾリジノン抗菌剤
|
GB9717807D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
KR100467309B1
(ko)
*
|
1997-09-04 |
2005-07-18 |
씨제이 주식회사 |
옥사졸리디논유도체및그의제조방법및항균제조성물
|
KR100463111B1
(ko)
*
|
1997-10-30 |
2005-06-13 |
씨제이 주식회사 |
신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
|
CA2303959A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
PT1304107E
(pt)
*
|
1997-11-18 |
2005-09-30 |
Pharmacia & Upjohn Co Llc |
Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
|
AU780197B2
(en)
*
|
1997-11-18 |
2005-03-10 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
NZ504612A
(en)
*
|
1997-11-18 |
2002-08-28 |
Upjohn Co |
Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
EP1049682A1
(en)
|
1998-01-23 |
2000-11-08 |
Versicor, Inc. |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
NZ506292A
(en)
*
|
1998-02-13 |
2003-05-30 |
Upjohn Co |
Substituted aminophenyl isoxazoline methylamide derivatives useful as antimicrobials
|
IL140084A0
(en)
|
1998-06-05 |
2002-02-10 |
Astra Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9812019D0
(en)
*
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
ATE384048T1
(de)
*
|
1998-09-22 |
2008-02-15 |
Astellas Pharma Inc |
Cyanophenyl-derivate
|
EP1133493A1
(en)
*
|
1998-11-27 |
2001-09-19 |
PHARMACIA & UPJOHN COMPANY |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
AU4224699A
(en)
|
1999-01-27 |
2000-08-18 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
IL147503A0
(en)
|
1999-07-28 |
2002-08-14 |
Upjohn Co |
Oxazolidinone compounds and methods of preparation and use thereof
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AR027261A1
(es)
*
|
2000-02-02 |
2003-03-19 |
Upjohn Co |
Linezolid forma cristalina ii
|
US6642238B2
(en)
|
2000-02-10 |
2003-11-04 |
Pharmacia And Upjohn Company |
Oxazolidinone thioamides with piperazine amide substituents
|
MY127336A
(en)
*
|
2000-03-22 |
2006-11-30 |
Upjohn Co |
Container for linezolid iv solution
|
US6514529B2
(en)
*
|
2000-03-22 |
2003-02-04 |
Pharmacia & Upjohn Company |
Oxazolidinone tablet formulation
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
JP2003535860A
(ja)
*
|
2000-06-05 |
2003-12-02 |
ドン・ア・ファーム・カンパニー・リミテッド |
新規なオキサゾリジノン誘導体及びその製造方法
|
US6544991B2
(en)
|
2000-06-30 |
2003-04-08 |
Pharmacia & Upjohn Company |
Compositions and methods for treating bacterial infections
|
US6734307B2
(en)
*
|
2000-07-17 |
2004-05-11 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
WO2003008389A1
(en)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
DE60118241T2
(de)
|
2000-10-17 |
2006-12-28 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Verfahren zur herstellung von oxazolidinonverbindungen
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
ES2186550B2
(es)
*
|
2001-06-27 |
2003-11-16 |
Vita Lab |
Nuevos derivados de oxazolidinonas como antibacterianos.
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
CN1639136A
(zh)
|
2001-09-11 |
2005-07-13 |
阿斯特拉曾尼卡有限公司 |
作为抗菌剂的噁唑烷酮和/或异噁唑啉
|
US7022705B2
(en)
|
2001-10-25 |
2006-04-04 |
Astrazeneca Ab |
Isoxazoline derivatives useful as antimicrobials
|
GB2396350A
(en)
*
|
2001-10-25 |
2004-06-23 |
Astrazeneca Ab |
Aryl substituted oxazolidinones with antibacterial activity
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
BR0307468A
(pt)
|
2002-02-05 |
2004-11-09 |
Upjohn Co |
Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
CN1642543A
(zh)
*
|
2002-03-29 |
2005-07-20 |
法玛西雅厄普约翰有限责任公司 |
治疗糖尿病性足部感染的噁唑烷酮肠胃外、静脉内和口服给药
|
AU2003231920A1
(en)
*
|
2002-04-01 |
2003-10-13 |
Cadila Healthcare Limited |
Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
|
PL373802A1
(en)
*
|
2002-05-15 |
2005-09-19 |
Ranbaxy Laboratories Limited |
Polymorphic forms of phenyl oxazolidinone derivatives
|
AU2002319848A1
(en)
*
|
2002-07-29 |
2004-02-25 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
EP1539745B1
(en)
*
|
2002-08-12 |
2006-03-29 |
Pharmacia & Upjohn Company LLC |
N-aryl-2-oxazolidinones and their derivatives
|
US20070167414A1
(en)
*
|
2002-08-22 |
2007-07-19 |
Orchid Chemicals & Pharmaceuticals Limited |
Novel antibacterial agents
|
AU2003253141A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Orchid Chemicals And Pharmaceuticals Ltd |
Novel antibacterial agents
|
WO2004026848A1
(en)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US6875784B2
(en)
|
2002-10-09 |
2005-04-05 |
Pharmacia & Upjohn Company |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
|
BR0315206A
(pt)
*
|
2002-10-10 |
2005-08-16 |
Pharmacia & Upjohn Co Llc |
Compostos antimicrobianos de 1-aril-diidropiridona
|
US7141570B2
(en)
*
|
2002-11-21 |
2006-11-28 |
Pharmacia & Upjohn Company |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
WO2004058732A1
(fr)
*
|
2002-12-30 |
2004-07-15 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Derive d'oxazolidine, technique de preparation et d'utilisations
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
CA2515311A1
(en)
*
|
2003-02-07 |
2004-08-19 |
Warner-Lambert Company Llc |
Antibacterial agents
|
BRPI0407304A
(pt)
*
|
2003-02-07 |
2006-01-10 |
Warner Lambert Co |
Agentes antibacterianos
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
WO2004089944A1
(en)
*
|
2003-04-07 |
2004-10-21 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
WO2004113329A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
BRPI0413838A
(pt)
*
|
2003-08-25 |
2006-10-24 |
Warner Lambert Co |
compostos de ariloxazolidinona antimicrobianos
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005051933A1
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
WO2005113520A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Pharmacia & Upjohn Company Llc |
Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
|
EP1658275A1
(en)
*
|
2004-06-29 |
2006-05-24 |
Teva Pharmaceutical Industries Ltd |
Crystalline form iv of linezolid
|
WO2006040614A1
(en)
*
|
2004-10-11 |
2006-04-20 |
Ranbaxy Laboratories Limited |
Substituted oxazolidinone derivatives
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
EP1866295A2
(en)
*
|
2005-02-24 |
2007-12-19 |
Teva Pharmaceutical Industries Ltd |
Processes for the preparation of linezolid intermediate
|
EP1874782A1
(en)
|
2005-04-15 |
2008-01-09 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
ES2335307T3
(es)
|
2005-06-29 |
2010-03-24 |
PHARMACIA & UPJOHN COMPANY LLC |
Homomorfolin oxalidinonas como agentes antibacterianos.
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
SG166126A1
(en)
|
2005-10-04 |
2010-11-29 |
Bayer Schering Pharma Ag |
Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
WO2008010070A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Orchid Research Laboratories Limited |
Novel oxazolidinone derivatives
|
US7593630B2
(en)
|
2006-07-24 |
2009-09-22 |
Foxconn Technology Co., Ltd. |
Built-in multidriver device for a camera zoom lens
|
US20100298384A1
(en)
*
|
2006-12-04 |
2010-11-25 |
Mohamed Takhi |
Novel oxazolidinone compounds as antiinfective agents
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
US20090093631A1
(en)
*
|
2007-09-06 |
2009-04-09 |
Ben-Zion Dolitzky |
Processes for the preparation of a linezolid intermediate, linezolid hydroxide
|
NZ587096A
(en)
*
|
2008-03-26 |
2011-11-25 |
Global Alliance For Tb Drug Dev |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
EP2138178A1
(en)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
|
EP2140866A1
(en)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
|
EP2757104B1
(en)
|
2008-10-10 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Compounds used in the synthesis of oxazolidinones
|
AU2009310952B2
(en)
*
|
2008-10-27 |
2015-04-30 |
Mitsubishi Tanabe Pharma Corporation |
Novel amide derivative and use thereof as medicine
|
CA2743971A1
(en)
|
2008-11-20 |
2010-05-27 |
Panacea Biotec Ltd. |
Novel antimicrobials
|
EP2393808B1
(en)
|
2009-02-03 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
CN103360379B
(zh)
*
|
2012-03-31 |
2017-05-24 |
南京圣和药业股份有限公司 |
噁唑烷酮化合物
|
WO2017156519A1
(en)
*
|
2016-03-11 |
2017-09-14 |
The Board Of Trustees Of The University Of Illinois |
Small-molecules active against gram-negative bacteria
|
WO2018237140A1
(en)
|
2017-06-23 |
2018-12-27 |
The Board Of Trustees Of The University Of Illinois |
TOPOISOMERASE INHIBITORS HAVING ANTIBACTERIAL ACTIVITY AND ANTI-CANCER ACTIVITY
|
CN112543756A
(zh)
|
2018-07-25 |
2021-03-23 |
卡迪拉保健有限公司 |
用于治疗哺乳动物感染的经取代噁唑烷酮类
|
CN110372624A
(zh)
*
|
2019-08-13 |
2019-10-25 |
北京海美桐医药科技有限公司 |
一种噁唑烷酮类化合物、其制备方法及应用
|
WO2021184339A1
(en)
*
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|
WO2024069378A1
(en)
*
|
2022-09-26 |
2024-04-04 |
Zydus Lifesciences Limited |
Novel compounds for the treatment of mammalian infections
|